Literature DB >> 9269481

In vitro dissolution profile comparison and IVIVR. Carbamazepine case.

P Sathe1, Y Tsong, V P Shah.   

Abstract

Dissolution data for the immediate or modified release drug products are usually collected as percent dissolved at multiple time points. Once an in-vitro/in-vivo relationship is established on a drug product, the dissolution profile becomes meaningful and important. In that context, if a firm desires to modify its formulation on which the in-vitro/in-vivo association has been established, a meaningful insight into the pharmacokinetics may be obtained by comparing the dissolution profiles of the two lots. In this presentation, we demonstrated a model dependent dissolution profile comparison approach using example of carbamazepine tablet dissolution data. Once a mathematical function was selected to describe the dissolution data coming from various standard lots, a similarity region could be constructed using the model parameter variances. To compare the test and reference lot dissolution profiles, a statistical distance was calculated between the mean parameters. A confidence region generated around the normalized mean statistical distance could then be compared with the similarity region to assess the similarity or dissimilarity of the dissolution profiles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269481     DOI: 10.1007/978-1-4684-6036-0_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate.

Authors:  María Esperanza Adrover; Marisa Pedernera; Magali Bonne; Bénédicte Lebeau; Verónica Bucalá; Loreana Gallo
Journal:  Saudi Pharm J       Date:  2019-11-13       Impact factor: 4.330

2.  Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.

Authors:  Sileshi Belew; Sultan Suleman; Markos Duguma; Henok Teshome; Evelien Wynendaele; Luc Duchateau; Bart De Spiegeleer
Journal:  Malar J       Date:  2020-04-07       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.